Xinling Pharmaceutical

company

About

Xinling Pharmaceutical is an innovative transdermal preparation platform company.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
¥100M
Founded date
Oct 1, 2019
Number Of Employee
11 - 50
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥100M
Xinling Pharmaceutical has raised a total of ¥100M in funding over 2 rounds. Their latest funding was raised on Mar 18, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 18, 2022 Seed ¥100M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Xinling Pharmaceutical is funded by 1 investors. China Science and Technology Innovation are the most recent investors.
Investor Name Lead Investor Funding Round
China Science and Technology Innovation Seed